Zelluna Immunotherapy
BioTech/Drugs - N/A, N/A, N/A
Zelluna Immunotherapy Employees
Zelluna Immunotherapy Senior Management
Zelluna Immunotherapy Details
Zelluna Immunotherapy is a company pioneering the development of allogeneic T cell receptor (TCR) guided natural killer (NK) cell immunotherapies for the treatment of solid cancers. The company is developing a portfolio of tumor specific TCRs to guide NK cells with the aim to induce cancer responses that are safe, efficient and durable. For more info please visit www.zelluna.com
Website:
zelluna.com
Employees:
20 - 49
HQ:
N/A
Location:
N/A, N/A, N/A
Revenue:
2.5 - 5 Million
Zelluna Immunotherapy Technologies
Captcha
reCAPTCHA
Email Providers
Outlook
Load Balancers
Apache
Tag Management
Google Tag Manager
Fonts
Typekit
Other
Microsoft Office 365